Fny Investment Advisers, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Fny Investment Advisers, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.28 - $1.16 $18,127 - $75,098	64,740 Added 57.8%	176,754 $59,000
Q1 2024 May 02, 2024	SELL	$1.06 - $1.67 $10,366 - $16,332	-9,780 Reduced 8.03%	112,014 $129,000
Q4 2023 Jan 12, 2024	BUY	$1.26 - $1.79 $75 - $107	60 Added 0.05%	121,794 $205,000
Q3 2023 Oct 10, 2023	BUY	$1.61 - $2.54 $128 - $203	80 Added 0.07%	121,734 $220,000
Q2 2023 Jul 11, 2023	BUY	$1.14 - $1.95 $28,499 - $48,750	25,000 Added 25.87%	121,654 $226,000
Q1 2023 Apr 12, 2023	SELL	$1.2 - $2.19 $9,120 - $16,644	-7,600 Reduced 7.29%	96,654 $128,000
Q4 2022 Jan 10, 2023	BUY	$1.63 - $3.52 $51,468 - $111,147	31,576 Added 43.45%	104,254 $176,000
Q3 2022 Oct 19, 2022	SELL	$0.73 - $3.74 $21,901 - $112,207	-30,002 Reduced 29.22%	72,678 $226,000
Q2 2022 Jul 12, 2022	BUY	$2.2 - $4.2 $33,836 - $64,596	15,380 Added 17.62%	102,680 $244,000
Q1 2022 Apr 25, 2022	BUY	$2.83 - $8.69 $225,381 - $692,071	79,640 Added 1039.69%	87,300 $351,000
Q4 2021 Jan 10, 2022	SELL	$8.31 - $14.92 $350,100 - $628,579	-42,130 Reduced 84.62%	7,660 $63,000
Q3 2021 Oct 13, 2021	BUY	$9.15 - $13.28 $455,578 - $661,211	49,790 New	49,790 $577,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.